KNSA - Financial Reports List - Kiniksa Pharmaceuticals, Ltd. - IntrinsicAlpha

Kiniksa Pharmaceuticals, Ltd. KNSA

Healthcare - Biotechnology - NASDAQ - BM

$ 25.935

-2.17 %

$ 1.89 B

Market Cap

-108.83

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	72.54%	148.23%	180.23%
Quarterly Report	Q4	8-K	2024-12-31	46.93%	-35.22%	-23825.93%
Annual Report	FY	10-K	2024-12-31	56.60%	-306.68%	-81.04%
Quarterly Report	Q3	8-K	2024-09-30	67.37%	8.39%	11.61%
Quarterly Report	Q2	8-K	2024-06-30	51.99%	-26.10%	96.29%
Quarterly Report	Q1	8-K	2024-03-31	65.18%	-44.29%	-47.75%
Quarterly Report	Q4	8-K	2023-12-31	34.76%	465.73%	-98.66%
Annual Report	FY	10-K	2023-12-31	22.74%	-92.32%	-341.83%
Quarterly Report	Q3	8-K	2023-09-30	-32.37%	-6.18%	-23.54%
Quarterly Report	Q2	8-K	2023-06-30	164.99%	174.93%	83.72%

1